Abstract:Antisolvent crystallization is commonly used in the formation of heat-sensitive compounds as it is the case for most active pharmaceutical ingredients. Membranes have the ability to control the antisolvent mass transfer to the reaction medium, providing excellent mixing that inhibits the formation of local supersaturations responsible for the undesired properties of the resulting crystals. Still, optimization of the operating conditions is required. This work investigates the impact of solution velocity, the effect of antisolvent composition, the temperature and gravity, using glycine-water-ethanol as a model crystallization system, and polypropylene flat sheet membranes. Results proved that in any condition, membranes were consistent in providing a narrow crystal size distribution (CSD) with coefficient of variation (CV) in the range of 0.5-0.6 as opposed to 0.7 obtained by batch and drop-by-drop crystallization. The prism-like shape of glycine crystals was maintained as well, but slightly altered when operating at a temperature of 35 °C with the appearance of smoother crystal edges. Finally, the mean crystal size was within 23 to 40 µm and did not necessarily follow a clear correlation with the solution velocities or antisolvent composition, but increased with the application of higher temperature or gravity resistance. Besides, the monoclinic form of α-glycine was perfectly maintained in all conditions. The results at each condition correlated directly with the antisolvent transmembrane flux that ranged between 0.0002 and 0.001 kg/m2. s. In conclusion, membrane antisolvent crystallization is a robust solution offering consistent crystal properties under optimal operating conditions.

Metastable Zone Width, Crystal Nucleation and Growth Kinetics Measurement in Anti-Solvent Crystallization of Β-Artemether in the Mixture of Ethanol and Water

Measurement and Correlation of the Solubility for β-Artemether in Five Organic Solvents

On-line Concentration Measurement for Anti-Solvent Crystallization of Β-Artemether Using UV–vis Fiber Spectroscopy

Determination of Solubility and Nucleation Kinetics of Valnemulin Hydrochloride Solvate

Antisolvent crystallization of biapenem: Estimation of growth and nucleation kinetics

Polymorphism, crystal structure and crystal habit of β-artemether

Solvent Effects on the Crystallization of Avermectin B1a

Determination of Crystallization Metastable Zone Width of Ciprofloxacin Hydrochloride in Alcohol Aqueous Solution

Binary and ternary complex formation and characterization of artemisinin with sulfobutyl ether β-cyclodextrin and oleic acid

Solubility of β-Artemether in Methanol + Water and Ethanol + Water from (288.85 to 331.95) K

Experimental and Model-Based Approach to Evaluate Solvent Effects on the Solubility of the Pharmaceutical Artemisinin

Insight into the Nucleation Mechanism of p-Methoxybenzoic Acid in Ethanol-Water System from Metastable Zone Width

Monitoring the Dissolution Behavior of Novel Pharmaceutical Cocrystals Consisting of Antimalarial Drug Artemisinin with Probe-Type Low-Frequency Raman Spectrometer

Study on the Nucleation Kinetics of DL-methionine Based on the Metastable Zone Width of Unseeded Batch Crystallization

Process Analytical Technology (PAT) Aided Identification of Operational Spaces Leading to Tailored Crystal Size Distributions in Azithromycin Crystallization Via Coordinated Cooling and Solution Mediated Phase Transition

Crystallization Kinetics of Tacrolimus Monohydrate in an Ethanol–Water System

Key Parameters Impacting the Crystal Formation in Antisolvent Membrane-Assisted Crystallization

Monitoring of Antisolvent Crystallization of Sodium Scutellarein by Combined FBRM–PVM–NIR

Nucleation kinetics of lovastatin in different solvents from metastable zone widths

Solubility Of Beta-Artemether In Methanol Plus Water And Ethanol Plus Water From (288.85 To 331.95) K

Simulation and On-line Real-time Measurement of Aspirin Crystalline Particle Size Distribution Based on Ultrasound